COVID-19 is a systemic infection that exerts significant impact on the metabolism. Yet, there
is little information on how SARS-CoV-2 affects metabolism. Using NMR spectroscopy, we …

COVID‐19 is a systemic infectious disease that may affect many organs, accompanied by a
measurable metabolic dysregulation. The disease is also associated with significant mortality…

Non-alcoholic steatohepatitis (NASH) is characterized by the accumulation of hepatic fat in
an inflammatory/fibrotic background. Herein, we show that the hepatic high-activity …

Background and Aims We previously identified subsets of patients with NAFLD with different
metabolic phenotypes. Here we align metabolomic signatures with cardiovascular disease (…

Quantitative plasma lipoprotein and metabolite profiles were measured on an autonomous
community of the Basque Country (Spain) cohort consisting of hospitalized COVID-19 …

Improved methods are required for investigating the systemic metabolic effects of SARS-CoV-2
infection and patient stratification for precision treatment. We aimed to develop an …

Background and Aims Hepatic ischemia–reperfusion injury (IRI) is the leading cause of
early posttransplantation organ failure as mitochondrial respiration and ATP production are …

Background Metabolic syndrome (MetS) is a multimorbid long-term condition without
consensual medical definition and a diagnostic based on compatible symptomatology. Here we …

There has been an intense focus to uncover the molecular mechanisms by which fasting
triggers the adaptive cellular responses in the major organs of the body. Here, we show that in …

COVID-19 is an infectious disease caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). COVID-19 is not only a lung disease but rather a systemic syndrome …